Table 2.
Comparison of derogatis interview for sexual functioning‐male (DISF‐M) scores
| Mean (SD) | ||||||
|---|---|---|---|---|---|---|
| DISF Domains | Group | Baseline (n = 25) | Week 4 (n = 25) | Week 8 (n = 25) | Mean difference (95% CI)a | p‐value (between group)* |
| Sexual cognition/fantasy | Ashwagandha | 17.48 (2.53) | 22.16 (2.52) | 23.08 (2.36) | −0.92 (−1.19 to −1.64) | <0.0001 |
| Placebo | 18.24 (2.57) | 21.84 (2.57) | 22.92 (2.62) | |||
| Sexual arousal | Ashwagandha | 14.60 (2.27) | 18.56 (2.29) | 19.44 (2.20) | −1.8 (−2.06 to −1.53) | <0.0001 |
| Placebo | 14.12 (1.69) | 16.04 (1.76) | 17.16 (1.72) | |||
| Sexual behavior | Ashwagandha | 13.56 (2.10) | 16.44 (2.16) | 18.40 (1.91) | −1.16 (−1.45 to −0.87) | <0.0001 |
| Placebo | 12.32 (1.84) | 14.52 (1.78) | 16.0 (1.58) | |||
| Orgasm | Ashwagandha | 6.68 (1.57) | 9.52 (1.61) | 11.28 (1.64) | −2.64 (−3.32 to −1.96) | <0.0001 |
| Placebo | 6.08 (1.46) | 7.88 (1.46) | 8.04 (2.44) | |||
| Sexual desire | Ashwagandha | 10.6 (0.91) | 14.4 (1.08) | 16.2 (1.0) | −3.28 (−3.67 to −2.88) | <0.0001 |
| Placebo | 10.32 (1.31) | 11.44 (1.82) | 12.64 (1.18) | |||
| Total score | Ashwagandha | 62.92 (4.75) | 81.08 (4.59) | 88.40 (4.87) | −9.8 (−10.73 to −8.87) | <0.0001 |
| Placebo | 61.08 (4.38) | 71.72 (4.59) | 76.76 (4.54) | |||
*
p‐value was obtained using independent two‐sample t‐test for mean change within the group (two‐tailed, α = 0.05).
a
Mean difference was obtained subtracting Week 8 and baseline differences in the ashwagandha and placebo groups.